Genocea Biosciences Inc Quick ratio

What is the Quick ratio of Genocea Biosciences Inc?

The Quick ratio of Genocea Biosciences Inc is 1.12

What is the definition of Quick ratio?



Quick ratio is liquidity ratio that measures a company’s ability to use its quick assets to meet its short-term obligations immediately.

mrq (most recent quarter)

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio of companies in the Health Care sector on NASDAQ compared to Genocea Biosciences Inc

What does Genocea Biosciences Inc do?

Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.

Companies with quick ratio similar to Genocea Biosciences Inc